Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NCL Investment Management, founded in 2015, is a UK-based venture capital firm specializing in healthcare investments. The firm focuses on providing equity capital to entrepreneurs developing technologies that modernize healthcare. NCL manages a portfolio of nine companies, emphasizing early-stage, high-growth businesses.
NCL Investment Management targets pre-seed to Series A investments in the healthcare and biotech sectors. The firm seeks out companies that are innovating to address a variety of health conditions, emphasizing technological advancements and transformational change in healthcare.
Notable portfolio companies include Ampersand Health, which focuses on long-term remission for inflammatory diseases; Azadyne, developing treatments for autoimmune diseases; and Centauri Therapeutics, specializing in immunotherapy for infectious diseases. Other investments include Curesponse, Emteq Labs, Revolo, Sana Health, TC Biopharm, and Viramel.
Submit your pitch through their form at nclim.co.uk.
NCL Investment Management invests in pre-seed, seed, seed+ (extension), and Series A stages.
The firm focuses on the healthcare and biotech sectors, targeting companies that are innovating in these areas.
Submit your pitch through their form at nclim.co.uk.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.